EP Patent

EP1240896A2 — Encapsulation of water soluble peptides

Assigned to Ipsen Pharma SAS · Expires 2002-09-18 · 24y expired

What this patent protects

A process for preparing polymer microspheres and nanospheres comprising a polymer and a peptide, which comprises the steps of: dissolving a salt of a peptide complexed with an anionically or cationically functionalized biodegradable polyester in an organic solvent to form a so…

USPTO Abstract

A process for preparing polymer microspheres and nanospheres comprising a polymer and a peptide, which comprises the steps of: dissolving a salt of a peptide complexed with an anionically or cationically functionalized biodegradable polyester in an organic solvent to form a solution; dispersing the solution in an aqueous solution of a surfactant; and evaporating the organic solvent to isolate the polymer microspheres and nanospheres.

Drugs covered by this patent

Patent Metadata

Patent number
EP1240896A2
Jurisdiction
EP
Classification
Expires
2002-09-18
Drug substance claim
No
Drug product claim
No
Assignee
Ipsen Pharma SAS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.